Revenue: The sum of all revenue fields included for a company's operating activities.
Madrigal Pharmaceuticals, Inc. (MDGL) had Revenue of $180.13M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$180.13M |
$-465.89M |
|
$6.23M |
|
$173.90M |
|
$678.01M |
|
$-497.88M |
|
$31.98M |
|
$-465.89M |
|
$-465.89M |
|
$-465.89M |
|
$-465.89M |
|
$-465.89M |
|
$-465.89M |
|
$-497.88M |
|
$-495.09M |
|
21.27M |
|
21.27M |
|
$-21.90 |
|
$-21.90 |
|
| Balance Sheet Financials | |
$1.03B |
|
$2.19M |
|
$9.32M |
|
$1.04B |
|
$169.28M |
|
$117.57M |
|
$118.59M |
|
$287.86M |
|
$754.38M |
|
$749.65M |
|
$754.38M |
|
22.00M |
|
| Cash Flow Statement Financials | |
$-455.57M |
|
$-274.39M |
|
$735.06M |
|
$99.92M |
|
$105.02M |
|
$5.10M |
|
$79.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.10 |
|
-- |
|
-- |
|
0.13 |
|
0.16 |
|
96.54% |
|
-276.39% |
|
-276.39% |
|
-274.85% |
|
-258.64% |
|
-258.64% |
|
$-457.03M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.18 |
|
3.35 |
|
109.06 |
|
-61.76% |
|
-62.15% |
|
-44.70% |
|
-53.43% |
|
$34.28 |
|
$-21.48 |
|
$-21.42 |
|